We are pleased to share we have acquired Lupin's women's health business! The acquisition of this commercial business aligns with and advances our mission to improve access to innovative and differentiated options that impact women's daily lives. SOLOSEC is a commercially attractive, single-dose oral antibiotic that addresses two pervasive sexual health infections. We can now fully leverage our commercial infrastructure, maximize our strong physician relationships, and re-launch an asset with tremendous growth potential.
We are pleased to share we have acquired Lupin's women's health business - now adding SOLOSEC® (secnidazole) 2g oral granules, an FDA-approved, single-dose oral treatment for two common sexual health infections, to our commercial portfolio of innovative sexual health drugs. This acquisition aligns with our strategy to leverage our U.S. women's health-focused sales organization, and marks an important milestone for the company and a new chapter in our evolution. https://lnkd.in/gxzb-DW6
Congratulations! Thank you for your commitment to women’s health!!
Heartiest Congratulations to Team Evofem
Well done on the acquisition! Very promising strategic move
Congratulations! We providers at Hello Alpha are proud prescribers of Solosec!
Nice product
Congrats 🎉 Saundra & Evofem Biosciences team! 🙌
Awesome! Congrats! Saundra Pelletier sure would love to catch up when you are able.
congratulations 👏
OB/GYN Physician Scientist | Leading Innovations in Women's Health through Clinical Development | Advocate for Reproductive Justice and Gender Equality
1moCongratulations on the acquisition! This marks an exciting new chapter for your company and a significant positive step for women's health.